Latest Stories
3 Reasons to Sell WERN and 1 Stock to Buy Instead
Werner’s 18.9% return over the past six months has outpaced the S&P 500 by 7.4%, and its stock price has climbed to $33.18 per share. This run-up might have investors contemplating their next move.
TPG (TPG): 3 Reasons We Love This Stock
TPG has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.7%. The stock now trades at $65.73, marking a 21.2% gain. This run-up might have investors contemplating their next move.
Leslie's (LESL): Buy, Sell, or Hold Post Q3 Earnings?
Leslie’s stock price has taken a beating over the past six months, shedding 80.3% of its value and falling to $1.58 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Sell THG and 1 Stock to Buy Instead
The Hanover Insurance Group has been treading water for the past six months, recording a small return of 4.5% while holding steady at $170.68. The stock also fell short of the S&P 500’s 11.5% gain during that period.
2 Reasons to Like UMBF (and 1 Not So Much)
UMB Financial trades at $120.73 per share and has stayed right on track with the overall market, gaining 13% over the last six months. At the same time, the S&P 500 has returned 11.5%.
First Bancorp (FBNC): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, First Bancorp has been a great trade, beating the S&P 500 by 9%. Its stock price has climbed to $55.41, representing a healthy 20.5% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid XRX and 1 Stock to Buy Instead
Xerox has gotten torched over the last six months - since July 2025, its stock price has dropped 48.7% to $2.50 per share. This might have investors contemplating their next move.
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers.
Semiconductor Manufacturing Stocks Q3 Highlights: Semtech (NASDAQ:SMTC)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at semiconductor manufacturing stocks, starting with Semtech (NASDAQ:SMTC).
Personal Loan Stocks Q3 Teardown: Atlanticus Holdings (NASDAQ:ATLC) Vs The Rest
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Atlanticus Holdings (NASDAQ:ATLC) and the best and worst performers in the personal loan industry.